Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
5.73
-0.14 (-2.39%)
At close: Sep 17, 2025, 4:00 PM EDT
5.84
+0.11 (1.92%)
After-hours: Sep 17, 2025, 5:50 PM EDT
Personalis Market Cap
Personalis has a market cap or net worth of $508.12 million as of September 17, 2025. Its market cap has increased by 54.52% in one year.
Market Cap
508.12M
Enterprise Value
380.81M
1-Year Change
54.52%
Ranking
Category
Stock Price
$5.73
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $847.61M to $508.12M, a decrease of -40.05%. That is a compound annual growth rate of -7.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 520.53M | 26.81% |
| Dec 31, 2024 | 410.49M | 298.67% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | 1.43B | 318.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.04B |
| Johnson & Johnson | 427.62B |
| AbbVie | 391.26B |
| UnitedHealth Group | 308.51B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 232.40B |